Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Researchers explored the role of the TLE6 protein in male fertility using a novel mouse model. TLE6 deficiency caused ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

For years, attempts have been made to cure type 1 diabetes, in which sufferers are dependent on insulin injections as soon as ...